What was the key brand positioning element that differentiated Humira when it first launched for rheumatoid arthritis treatment?

In the competitive pharmaceutical industry, brand positioning can make or break a product. When Humira (adalimumab) launched in 2002, it revolutionized treatment for rheumatoid arthritis and eventually expanded to multiple autoimmune conditions. Its brand positioning was distinctive in the medical market and helped it achieve remarkable success. This poll tests your knowledge about how AbbVie positioned this groundbreaking biologic treatment when it first entered the market.

This is a live public trivia poll on AIPolls.Net. Vote and see real-time results.

First self-administered injectable biologic therapy patients could use at home
Lowest cost TNF inhibitor on the market
First rheumatoid arthritis treatment with no side effects
Only treatment combining traditional DMARDs with biologics in one injection